SynDiag
Activity description
SynDiag is a Fem Tech and Med Tech startup, founded in 2019 as a spin off company of the Polytechnic University of Turin. SynDiag has developed OvAi to allow the early diagnosis of ovarian cancer, the deadliest cancer among women cancers due to late diagnosis. OvAi is a Software as a Medical Device, CE marked, based on Artificial Intelligence for both objective reading of ultrasound exams and for virtual biopsy of detected ovarian tumors. OvAi can be adopted during any visits and acts as an expert colleague, always available to provide an explainable second opinion on diagnostic decisions.
Supply Chain
Manufacturing
Medtech
Medical Device
Digital Health
Services
(i.e Consulting, Training, Analysis)
